Clinical Trial Update: Oral Bifidobacterium Longum for Skin Barrier Dysfunction in Obesity [NA]

View source ↗

Summary

Clinical trial update shows completion of a study evaluating oral Bifidobacterium longum for skin barrier dysfunction in obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Oral Bifidobacterium Longum (Bifidobacterium longum)

Snippet

Sponsor: Shenzhen People's Hospital | Conditions: Skin Barrier to Water Loss, Microbial Colonization | NA | Status: COMPLETED